← Back to Search
Macrophage Functionality And Homeostasis In Response To Oligoethyleneglycol-coated IONPs: Impact Of A Dendritic Architecture.
A. Casset, J. Jouhannaud, A. Garofalo, C. Spiegelhalter, D. Nguyen, D. Felder-Flesch, G. Pourroy, F. Pons
Published 2019 · Chemistry, Medicine
Download PDFAnalyze on Scholarcy
The engineering of iron oxide nanoparticles (IONPs) for biomedical use has received great interest over the past decade. In the present study we investigated the biocompatibility of IONPs grafted with linear (2P) or generation 1 (2PG1) or 2 (2PG2) dendronized oligoethyleneglycol units in THP-1-derived macrophages. To evaluate IONP effects on cell functionality and homeostasis, mitochondrial function (MTT assay), membrane permeability (LDH release), inflammation (IL-8), oxidative stress (reduced glutathione, GSH), NLRP3 inflammasome activation (IL-1β) and nanoparticle cellular uptake (intracellular iron content) were quantified after a 4-h or 24-h cell exposure to increasing IONP concentrations (0-300 µg Fe/mL). IONPs coated with a linear molecule, NP10COP@2P, were highly taken up by cells and induced significant dose-dependent IL-8 release, oxidative stress and NLRP3 inflammasome activation. In comparison, IONPs coated with dendrons of generation 1 (NP10COP@2PG1) and 2 (NP10COP@2PG2) exhibited better biocompatibility. Effect of the dendritic architecture of the surface coating was investigated in a kinetic experiment involving cell short-term exposure (30 min or 1 h 30) to the two dendronized IONPs. NP10COP@2PG2 disrupted cellular homeostasis (LDH release, IL-1β and IL-8 secretion) to a greater extend than NP10COP@2PG1, which makes this last IONP the best candidate as MRI contrast or theranostic agent.
This paper references
Efficient internalization of silica-coated iron oxide nanoparticles of different sizes by primary human macrophages and dendritic cells.
A. Kunzmann (2011)
Development of a fluorescence-based microtiter plate method for the measurement of glutathione in yeast.
Kamil Lewicki (2006)
Sentinel lymph node identification using superparamagnetic iron oxide particles versus radioisotope: The French Sentimag feasibility trial
Jean-Louis Houpeau (2016)
Iron oxide nanoparticle agglomeration influences dose rates and modulates oxidative stress-mediated dose–response profiles in vitro
G. Sharma (2014)
Phagolysosome acidification is required for silica and engineered nanoparticle‐induced lysosome membrane permeabilization and resultant NLRP3 inflammasome activity
F. Jessop (2017)
Synthesis, surface architecture and biological response of superparamagnetic iron oxide nanoparticles for application in drug delivery: a review
M. Mahmoudi (2010)
Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications
P. Reimer (2002)
SPION primes THP1 derived M2 macrophages towards M1-like macrophages.
Amit Laskar (2013)
M2 polarization enhances silica nanoparticle uptake by macrophages
J. Hoppstädter (2015)
Studying the effect of particle size and coating type on the blood kinetics of superparamagnetic iron oxide nanoparticles
F. Roohi (2012)
Flow cytometry for intracellular SPION quantification: specificity and sensitivity in comparison with spectroscopic methods
R. Friedrich (2015)
High intracellular iron oxide nanoparticle concentrations affect cellular cytoskeleton and focal adhesion kinase-mediated signaling.
S. Soenen (2010)
Toxicity of Metal Oxide Nanoparticles in Mammalian Cells
H. Jeng (2006)
Properties and suspension stability of dendronized iron oxide nanoparticles for MRI applications.
B. Basly (2011)
Oxidative damage to biological macromolecules in human bone marrow mesenchymal stromal cells labeled with various types of iron oxide nanoparticles.
B. Novotná (2012)
Universal cell labelling with anionic magnetic nanoparticles.
C. Wilhelm (2008)
Water soluble dendronized iron oxide nanoparticles.
T. J. Daou (2009)
Adverse Reactions After Intravenous Iron Infusion Among Inflammatory Bowel Disease Patients in the United States, 2010-2014.
Eboselume Akhuemonkhan (2018)
Evaluation of the Active Targeting of Melanin Granules after Intravenous Injection of Dendronized Nanoparticles.
C. Bordeianu (2018)
Enhanced cellular uptake of aminosilane-coated superparamagnetic iron oxide nanoparticles in mammalian cell lines
X. Zhu (2012)
'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption.
Cytotoxic effects of iron oxide nanoparticles and implications for safety in cell labelling.
Stefaan J.H. Soenen (2011)
The influence of protein adsorption on nanoparticle association with cultured endothelial cells.
Morton Ehrenberg (2009)
Effect of the nanoparticle synthesis method on dendronized iron oxides as MRI contrast agents.
B. Basly (2013)
Recent advances in magnetic structure determination by neutron powder diffraction
J. Rodríguez-Carvajal (1993)
Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles.
M. Mahmoudi (2012)
Mechanism of NLRP3 inflammasome activation
F. Sutterwala (2014)
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Catherine Dostert (2008)
Quantifying intra- and extracellular aggregation of iron oxide nanoparticles and its influence on specific absorption rate.
Seongho Jeon (2016)
Protein corona acts as a protective shield against Fe3O4-PEG inflammation and ROS-induced toxicity in human macrophages.
V. Escamilla-Rivera (2016)
Transport across the cell-membrane dictates nanoparticle fate and toxicity: a new paradigm in nanotoxicology.
D. Guarnieri (2014)
Simplified preparation and characterization of magnetic hydroxyapatite-based nanocomposites.
Stefania Scialla (2017)
The role of iron redox state in the genotoxicity of ultrafine superparamagnetic iron oxide nanoparticles.
N. Singh (2012)
Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress
S. Naqvi (2010)
Validation of a dendron concept to tune colloidal stability, MRI relaxivity and bioelimination of functional nanoparticles.
A. Walter (2015)
Immunomodulatory properties of multi-walled carbon nanotubes in peripheral blood mononuclear cells from healthy subjects and allergic patients.
G. Laverny (2013)
Iron oxide nanoparticles suppress the production of IL-1beta via the secretory lysosomal pathway in murine microglial cells
Hsin-Ying Wu (2013)
K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter.
Raúl Muñoz-Planillo (2013)
Magnetic Iron Oxide Nanoparticles in 10−40 nm Range: Composition in Terms of Magnetite/Maghemite Ratio and Effect on the Magnetic Properties
J. Salazar (2011)
Coronary MR angiography using citrate‐coated very small superparamagnetic iron oxide particles as blood‐pool contrast agent: Initial experience in humans
M. Wagner (2011)
Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro.
K. Mueller (2007)
Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells.
D. Thorek (2008)
Effects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticles.
J. Huang (2010)
In vitro toxicity of nanoparticles in BRL 3A rat liver cells.
S. Hussain (2005)
Dysregulation of macrophage activation profiles by engineered nanoparticles.
V. Kodali (2013)
ATP Activates a Reactive Oxygen Species-dependent Oxidative Stress Response and Secretion of Proinflammatory Cytokines in Macrophages*
Christiane Monteiro da Cruz (2007)
Oxidative Stress and Dermal Toxicity of Iron Oxide Nanoparticles In Vitro
A. Murray (2012)
Ferumoxytol for the treatment of iron deficiency anemia
M. Auerbach (2018)
Macrophage Endocytosis of Superparamagnetic Iron Oxide Nanoparticles: Mechanisms and Comparison of Ferumoxides and Ferumoxtran-10
I. Raynal (2004)
Time-course assessment of the aggregation and metabolization of magnetic nanoparticles.
J. M. Rojas (2017)
Cell-specific cytotoxicity of dextran-stabilized magnetite nanoparticles.
J. Ding (2010)
Aspergillus fumigatus Stimulates the NLRP3 Inflammasome through a Pathway Requiring ROS Production and the Syk Tyrosine Kinase
Najwane Saïd-Sadier (2010)
PEG-mediated synthesis of highly dispersive multifunctional superparamagnetic nanoparticles: their physicochemical properties and function in vivo.
C. Sun (2010)
Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging
Jaehyun Lee (2007)
Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: synthesis, physicochemical characterization, and in vitro experiments.
Fabio Sonvico (2005)
Assessing methods for blood cell cytotoxic responses to inorganic nanoparticles and nanoparticle aggregates.
B. Díaz (2008)
Actively-targeted LTVSPWY peptide-modified magnetic nanoparticles for tumor imaging
Li-Yong Jie (2012)
Silver Nanoparticles Induce Degradation of the Endoplasmic Reticulum Stress Sensor Activating Transcription Factor-6 Leading to Activation of the NLRP-3 Inflammasome
J. Simard (2015)
Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake.
Carl D. Walkey (2012)
Effect of Culture Conditions on the Phenotype of THP‐1 Monocyte Cell Line
P. Aldo (2013)
In vitro toxicity of iron oxide nanoparticle: oxidative damages on Hep G2 cells.
L. Sadeghi (2015)
Size-dependent toxicity of metal oxide particles--a comparison between nano- and micrometer size.
H. Karlsson (2009)
Dextran and Polymer Polyethylene Glycol (PEG) Coating Reduce Both 5 and 30 nm Iron Oxide Nanoparticle Cytotoxicity in 2D and 3D Cell Culture
M. Yu (2012)
Biodegradation of iron oxide nanocubes: high-resolution in situ monitoring.
Lénaic Lartigue (2013)
Magnetic ferroferric oxide nanoparticles induce vascular endothelial cell dysfunction and inflammation by disturbing autophagy.
L. Zhang (2016)
Effects of metal(loid)-based nanomaterials on essential element homeostasis: the central role of nanometallomics for nanotoxicology.
F. Benetti (2014)
The nanosilica hazard: another variable entity
D. Napierska (2010)
Tailored functionalization of iron oxide nanoparticles for MRI, drug delivery, magnetic separation and immobilization of biosubstances.
K. Holá (2015)
Iron oxide nanoparticles modulate lipopolysaccharide-induced inflammatory responses in primary human monocytes
S. Grosse (2016)
Modulation of Human Macrophage Responses to Mycobacterium tuberculosis by Silver Nanoparticles of Different Size and Surface Modification
S. Sarkar (2015)
Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization
V. Hornung (2008)
The role of reactive oxygen species in the genotoxicity of surface-modified magnetite nanoparticles.
M. Mesárošová (2014)
Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles.
A. Gupta (2005)
Dendronized iron oxide nanoparticles for multimodal imaging.
G. Lamanna (2011)
Rapid binding of electrostatically stabilized iron oxide nanoparticles to THP-1 monocytic cells via interaction with glycosaminoglycans
A. Ludwig (2013)
Rietveld refinement of Debye–Scherrer synchrotron X‐ray data from Al2O3
P. Thompson (1987)
Signal changes in liver and spleen after Endorem administration in patients with and without liver cirrhosis
W. Hundt (2000)
Oxidative stress response in neural stem cells exposed to different superparamagnetic iron oxide nanoparticles
Igor M. Pongrac (2016)
Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging.
R. Weissleder (1990)
Mastering the Shape and Composition of Dendronized Iron Oxide Nanoparticles To Tailor Magnetic Resonance Imaging and Hyperthermia
A. Walter (2014)
Multiple Cathepsins Promote Pro–IL-1β Synthesis and NLRP3-Mediated IL-1β Activation
G. Orlowski (2015)
Dendronized iron oxide nanoparticles as contrast agents for MRI.
B. Basly (2010)
In vitro evaluation of the cytotoxicity of iron oxide nanoparticles with different coatings and different sizes in A3 human T lymphocytes.
Er-Bo Ying (2010)
Mechanism and Regulation of NLRP3 Inflammasome Activation.
Y. He (2016)
Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells.
N. Kohler (2005)
Efficient synthesis of small-sized phosphonated dendrons: potential organic coatings of iron oxide nanoparticles
A. Garofalo (2014)
(Intra)cellular stability of inorganic nanoparticles: effects on cytotoxicity, particle functionality, and biomedical applications.
S. Soenen (2015)
Cell compatibility of a maghemite/polymer biomedical nanoplatform.
Lamiaa M. A. Ali (2015)
This paper is referenced by
Mastering bioactive coatings of metal oxide nanoparticles and surfaces through phosphonate dendrons
Dinh Vu Nguyen (2020)
Metronidazole-functionalized iron oxide nanoparticles for molecular detection of hypoxic tissues.
Miriam Filippi (2019)
Microbubbles decorated with dendronized magnetic nanoparticles for biomedical imaging: effective stabilization via fluorous interactions
D. Shi (2019)